Billings Clinic
Especially For:

Clinical Trials

Title   GOG-01861 Recurrent Ovarian, fallopian tube, primary peritoneal cancer
Description   A RANDOMIZED PHASE II EVALUATION OF SINGLE-AGENT BEVACIZUMAB & COMBINATION BEVACIZUMAB WITH FOSBRETABULIN TROMETHAMINE (CA4P) (NSC #752293) IN THE TREATMENT OF RECURRENT OR PERSISTENT EPITHELIAL OVARIAN, Fallopian TUBE OR PRIMARY PERITONEAL CARCINOMA
IRB Number   GOG-01861
Category   Gynencology
Status   Active
Start Date   01/09/2012
Principal Investigator (PI)   Randall Gibb, MD
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.